Feb 9 (Reuters) - Heart devices maker World Heart Corporation (WHRT.O) said it suspended patient enrollment for its heart device study as it awaits regulatory approval for certain changes made in the device.
Feb 9 (Reuters) - Heart devices maker World Heart Corporation (WHRT.O) said it suspended patient enrollment for its heart device study as it awaits regulatory approval for certain changes made in the device.